Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.0
-101.38%
20%
—
6x
Every year
—
5 Years
Score4.0
Net Growth-101.38%
Net Trend20%
Net Income Consistency—
Rev Growth6x
Rev TrendEvery year
Revenue Consistency—
Insmed Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 164M to $ 606M and net income went from -$ 294M to -$ 1.27B. Revenue increased in every one of those 5 years; net income in 1.
Across Insmed Inc's full reported history, from 2000 to 2025, revenue grew from $ 60K to $ 606M and net income went from -$ 79M to -$ 1.27B. Revenue increased in 58% of the years measured; net income in 35%.
Insmed Inc currently holds a 20-year HDB Score of 2.8 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 132.28 | — |
1 Year2025-08-12 | $ 122.00 | 8.43% |
5 Years2021-08-12 | $ 23.92 | 453.01% |
10 Years2016-08-12 | $ 11.91 | 11x |
20 Years2006-08-11 | $ 10.80 | 12x |
30 Years1996-08-12 | $ 2.56 | 51x |
All Time2000-06-01 | $ 165.00 | -19.83% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | 30 Years1996-08-12 | All Time2000-06-01 |
|---|---|---|---|---|---|---|---|
| Price | $ 132.28 | $ 122.00 | $ 23.92 | $ 11.91 | $ 10.80 | $ 2.56 | $ 165.00 |
| Return | — | 8.43% | 453.01% | 11x | 12x | 51x | -19.83% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 1.13B | -$ 875M | $ 1.16B |
| 2025 | $ 606M | -$ 1.27B | $ 1.43B |
| 2024 | $ 363M | -$ 913M | $ 1.43B |
| 2023 | $ 305M | -$ 749M | $ 780M |
| 2022 | $ 245M | -$ 481M | $ 1.14B |
| 2021 | $ 188M | -$ 434M | $ 716M |
| 2020 | $ 164M | -$ 294M | $ 532M |
| 2019 | $ 136M | -$ 254M | $ 487M |
| 2018 | $ 9M | -$ 324M | $ 495M |
| 2017 | $ 0.00 | -$ 192M | $ 381M |
| 2016 | $ 0.00 | -$ 176M | $ 162M |
| 2015 | $ 0.00 | -$ 118M | $ 282M |
| 2014 | $ 11M | -$ 79M | $ 159M |
| 2013 | $ 11M | -$ 56M | $ 113M |
| 2012 | $ 0.00 | -$ 41M | $ 92M |
| 2011 | $ 4M | -$ 59M | $ 76M |
| 2010 | $ 6M | -$ 6M | $ 108M |
| 2009 | $ 10M | $ 118M | $ 122M |
| 2008 | $ 11M | -$ 15M | $ 2M |
| 2007 | $ 7M | -$ 19M | $ 16M |
| 2006 | $ 991K | -$ 56M | $ 24M |
| 2005 | $ 131K | -$ 40M | $ 18M |
| 2004 | $ 137K | -$ 27M | $ 9M |
| 2003 | $ 150K | -$ 10M | $ 29M |
| 2002 | $ 1M | -$ 36M | $ 27M |
| 2001 | $ 296K | -$ 37M | $ 51M |
| IPO2000 | $ 60K | -$ 79M | $ 83M |
Explore beyond INSM
You're looking at Insmed Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
